Status:
UNKNOWN
Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS)
Lead Sponsor:
Allergy and Asthma Center of El Paso
Collaborating Sponsors:
GlaxoSmithKline
Conditions:
Asthma
Eligibility:
All Genders
12-45 years
Phase:
PHASE4
Brief Summary
The objectives of this study are to measure Impulse Oscillometry (IOS) in patients with asthma extensively at baseline in patients with mild-to-moderate asthma, treated with as-needed short acting bet...
Detailed Description
Eligibility criteria include age 12-45 years, with current treatment of asthma with as-needed SABA only; and manifesting an acute response to SABA at screening of 40% or greater improvement in IOS low...
Eligibility Criteria
Inclusion
- Clinical diagnosis of asthma
- Asthma symptoms controlled by short-acting beta agonist as-needed
- Age 12-45 years
Exclusion
- Severe asthma
- use of oral or inhaled corticosteroids within 30 days of screening
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00867737
Start Date
September 1 2008
End Date
September 1 2009
Last Update
March 24 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Allergy and Asthma Center of El Paso
El Paso, Texas, United States, 79925